Disclosures for "Phosphodiesterase-5 Inhibitor Use Is Associated with a 60-61% Relative Decrease in the Rate of Parkinson’s Disease: A Cohort Study Supporting the Need for a Phase Three Clinical Trial"
-
Dr. Henry has received research support from Baptist Health Center for Clinical Research.
-
Dr. Pellegrino has nothing to disclose.